Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
作者信息
Weninger Stacie, Carrillo Maria C, Dunn Billy, Aisen Paul S, Bateman Randall J, Kotz Joanne D, Langbaum Jessica B, Mills Susan L, Reiman Eric M, Sperling Reisa, Santacruz Anna M, Tariot Pierre N, Welsh-Bohmer Kathleen A
机构信息
F-Prime Biomedical Research Initiative, Cambridge, MA, USA.
Medical & Scientific Relations Division, Alzheimer's Association, Chicago, IL, USA.
出版信息
Alzheimers Dement. 2016 May;12(5):631-2. doi: 10.1016/j.jalz.2016.04.001.
Abstract
摘要
相似文献
1
Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
Alzheimers Dement. 2016 May;12(5):631-2. doi: 10.1016/j.jalz.2016.04.001.
2
Global Data Sharing in Alzheimer Disease Research.
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):160-8. doi: 10.1097/WAD.0000000000000121.
3
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.
Alzheimers Dement. 2013 Mar;9(2):123-131.e1. doi: 10.1016/j.jalz.2012.12.004. Epub 2013 Feb 12.
4
The Global Alzheimer's Association Interactive Network.
Alzheimers Dement. 2016 Jan;12(1):49-54. doi: 10.1016/j.jalz.2015.06.1896. Epub 2015 Aug 28.
5
Preclinical Alzheimer's disease therapeutics.
J Alzheimers Dis. 2014;42 Suppl 4:S545-9. doi: 10.3233/JAD-141482.
6
A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease.
Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.
7
Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
J Alzheimers Dis. 2016;50(4):927-45. doi: 10.3233/JAD-150826.
8
GISAID: Global initiative on sharing all influenza data - from vision to reality.
Euro Surveill. 2017 Mar 30;22(13). doi: 10.2807/1560-7917.ES.2017.22.13.30494.
9
Leveraging global resources to end the Alzheimer's pandemic.
Alzheimers Dement. 2013 Jul;9(4):363-5. doi: 10.1016/j.jalz.2013.05.1768.
10
Sharing data in the global alzheimer's association interactive network.
Neuroimage. 2016 Jan 1;124(Pt B):1168-1174. doi: 10.1016/j.neuroimage.2015.05.082. Epub 2015 Jun 4.
引用本文的文献
1
Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline.
Alzheimers Dement. 2025 Jun;21(6):e70351. doi: 10.1002/alz.70351.
2
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
Acta Neuropathol. 2025 Jun 3;149(1):57. doi: 10.1007/s00401-025-02890-7.
3
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.
Brain. 2025 Feb 4. doi: 10.1093/brain/awaf038.
4
Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data.
J Prev Alzheimers Dis. 2024;11(4):889-894. doi: 10.14283/jpad.2024.120.
5
Editorial: Introduction to the Special Issue on the A4 Study.
J Prev Alzheimers Dis. 2024;11(4):801. doi: 10.14283/jpad.2024.118.
6
Data stewardship in FTLD research: Investigator and research participant views.
Alzheimers Dement. 2024 Apr;20(4):2886-2893. doi: 10.1002/alz.13719. Epub 2024 Mar 8.
7
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.
Alzheimers Dement. 2024 Mar;20(3):1839-1850. doi: 10.1002/alz.13532. Epub 2023 Dec 25.
8
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.
Alzheimers Dement. 2023 May;19(5):1938-1946. doi: 10.1002/alz.12843. Epub 2022 Nov 14.
9
Early termination of pivotal trials in Alzheimer's disease-Preserving optimal value for participants and science.
Alzheimers Dement. 2022 Oct;18(10):1980-1987. doi: 10.1002/alz.12605. Epub 2022 Feb 27.
10
The Use of Remote Monitoring Technologies: A Review of Recent Regulatory Scientific Advices, Qualification Opinions, and Qualification Advices Issued by the European Medicines Agency.
Front Med (Lausanne). 2021 Jul 1;8:619513. doi: 10.3389/fmed.2021.619513. eCollection 2021.
Zotero 插件